Literature DB >> 1555995

Diagnostic validity of fecal occult blood tests for detecting gastroenterological cancers.

R Murakami1, T Otani, K Nakanishi, Y Fudemoto, H Ishikawa, T Hiyama, H Tsukuma, I Fujimoto, N Miki, A Oshima.   

Abstract

In order to estimate the diagnostic validity of chemical fecal occult blood tests, i.e. orthotolidine (Shionogi A) and guajac (Shionogi B) slides for detecting cancers of the esophagus, stomach and colorectum, the authors followed up all the examinees (n = 3,449) of comprehensive medical check-ups at the Center for Adult Diseases, Osaka, by means of record linkage to the Osaka Cancer Registry's files. Then, diagnostic validity was calculated based on the results of two years' follow-up. Sensitivity for the respective cancers was 20.0%, 11.8% and 62.5% for Shionogi A, and 20.0%, 5.9% and 43.8% for Shionogi B slides. Likelihood ratio for the respective cancers was 1.4, 0.8 and 4.5 for Shionogi A, and 3.3, 1.0 and 7.5 for Shionogi B. Specificity was analogous among the three cancer sites, being 86% for Shionogi A and 94% for Shionogi B. These results suggest that the diagnostic validity of chemical occult blood tests for detecting cancers of the esophagus and the stomach is very poor, and therefore imply that close examinations of these sites for screening positives is unnecessary in mass screenings for colorectal cancer.

Entities:  

Mesh:

Year:  1992        PMID: 1555995      PMCID: PMC5918787          DOI: 10.1111/j.1349-7006.1992.tb00078.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  4 in total

1.  Likelihood ratios with confidence: sample size estimation for diagnostic test studies.

Authors:  D L Simel; G P Samsa; D B Matchar
Journal:  J Clin Epidemiol       Date:  1991       Impact factor: 6.437

2.  Sensitivity, specificity, and positive predictivity of the Hemoccult test in screening for colorectal cancers. The University of Minnesota's Colon Cancer Control Study.

Authors:  J S Mandel; J H Bond; M Bradley; D C Snover; T R Church; S Williams; G Watt; L M Schuman; F Ederer; V Gilbertsen
Journal:  Gastroenterology       Date:  1989-09       Impact factor: 22.682

3.  Basic issues in population screening for cancer.

Authors:  P Cole; A S Morrison
Journal:  J Natl Cancer Inst       Date:  1980-05       Impact factor: 13.506

Review 4.  Occult blood screening for colorectal carcinoma: a critical review.

Authors:  J B Simon
Journal:  Gastroenterology       Date:  1985-03       Impact factor: 22.682

  4 in total
  2 in total

Review 1.  Effect of verification bias on the sensitivity of fecal occult blood testing: a meta-analysis.

Authors:  Alan S Rosman; Mark A Korsten
Journal:  J Gen Intern Med       Date:  2010-05-25       Impact factor: 5.128

2.  Immunochemical fecal occult blood test is inadequate for screening test of stomach cancer.

Authors:  H Nakama; B Zhang
Journal:  Dig Dis Sci       Date:  2000-11       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.